plus_logo.png
Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 14, 2024 16:16 ET | Plus Therapeutics Inc.
Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
plus_logo.png
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
August 13, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
plus_logo.png
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference
August 12, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference
plus_logo.png
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024
August 08, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024
plus_logo.png
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference
July 25, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference
plus_logo.png
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
July 02, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
plus_logo.png
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
June 07, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
plus_logo.png
Plus Therapeutics Announces New Employment Inducement Grants
May 17, 2024 17:00 ET | Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
plus_logo.png
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 15, 2024 16:15 ET | Plus Therapeutics Inc.
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
plus_logo.png
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
May 13, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024